Maximus, Inc.: Strategic Portfolio Realignment for Global Expansion Driving Our ‘Buy’ Rating! 

Maximus recently reported its fiscal year 2024 earnings, illustrating a robust financial performance underpinned by strategic advancements and significant contracts, albeit amid some challenges and uncertainties. For the year, Maximus achieved 8.2% growth in consolidated revenue, amounting to $5.31 billion, with organic growth at 8.8%. This was driven by increased volumes in core programs and Medicaid-related activities, reflecting the resumption to pre-pandemic levels and additional volumes managed throughout the year.